BANK OF MONTREAL /CAN/ - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 60 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q2 2021$1,202,000
+123.8%
399,192
+99.3%
0.00%
Q1 2021$537,000
-33.0%
200,317
-23.7%
0.00%
-100.0%
Q4 2020$802,000
+112.2%
262,496
+49.0%
0.00%
Q3 2020$378,000
+2807.7%
176,203
+4820.5%
0.00%
Q2 2020$13,000
+333.3%
3,581
+162.5%
0.00%
Q1 2020$3,000
-97.8%
1,364
-97.9%
0.00%
Q4 2019$139,000
+1290.0%
66,486
+1523.2%
0.00%
Q3 2019$10,000
+11.1%
4,096
+35.6%
0.00%
Q2 2019$9,0003,0210.00%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q2 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 978,907$6,865,0003.28%
RA Capital Management 2,690,702$20,449,0002.02%
NEA Management Company, LLC 2,141,308$16,274,0001.04%
Broadfin Capital, LLC 1,656,705$10,911,0000.67%
Tredje AP-fonden 909,581$6,913,0000.44%
Granite Point Capital Management, L.P. 388,945$2,679,0000.40%
Ghost Tree Capital, LLC 72,726$553,0000.23%
SPHERA FUNDS MANAGEMENT LTD. 181,818$1,382,0000.20%
Tower Research Capital LLC (TRC) 1,094$8,0000.00%
ACADIAN ASSET MANAGEMENT LLC 1,373$10,0000.00%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders